Authors

• Mark Hatherill (ORCID: https://orcid.org/0000-0003-3491-1809)
• Natasja Botes
• Carly Young (ORCID: https://orcid.org/0000-0002-2338-8314)
• Eugenia Puentes
• Ashley Veldsman
• Humphrey Mulenga (ORCID: https://orcid.org/0000-0002-2030-0751)
• Hennie Geldenhuys (ORCID: https://orcid.org/0000-0002-2221-8997)
• Justin Shenje (ORCID: https://orcid.org/0000-0003-3054-3930)
• Claire Imbratta
• Nacho Aguiló (ORCID: https://orcid.org/0000-0001-7897-9173)
• Simon C. Mendelsohn (ORCID: https://orcid.org/0000-0002-4054-2766)
• Jesús Gonzalo‐Asensio (ORCID: https://orcid.org/0000-0001-8841-6593)
• Michèle Tameris (ORCID: https://orcid.org/0000-0002-7983-7203)
• Dessislava Marinova (ORCID: https://orcid.org/0000-0003-0918-9551)
• Rajat Mukherjee (ORCID: https://orcid.org/0000-0001-7905-2767)
• Juana Doce
• Thomas J. Scriba (ORCID: https://orcid.org/0000-0002-0641-1359)
• Virginie Rozot (ORCID: https://orcid.org/0000-0001-9757-1501)
• Angelique Kany Kany Luabeya (ORCID: https://orcid.org/0000-0001-7379-2836)
• Esteban Rodríguez (ORCID: https://orcid.org/0000-0003-3277-6682)
• Michelle Fisher (ORCID: https://orcid.org/0000-0003-1414-7612)
• Jelle Thole (ORCID: https://orcid.org/0000-0003-0873-1783)
• Bernard Fritzell
• Nicole Bilek
• Ingrid Murillo Jelsbak
• Nicolette Tredoux
• Carlos Martı́n (ORCID: https://orcid.org/0000-0003-2993-5478)

Institutions

• University of Cape Town (ZA)
• Instituto de Salud Carlos III (ES)
• South African Tuberculosis Vaccine Initiative (ZA)
• Asociación de Investigación Metalúrgica del Noroeste (ES)
• FC Barcelona (ES)
• Complejo Hospitalario de Pontevedra (ES)

Publication Details

Journal

EBioMedicine

Published

2025-03-17

DOI

https://doi.org/10.1016/j.ebiom.2025.105628

Citations

8

Primary Topic

Tuberculosis Research and Epidemiology

Type

article

Field-Weighted Citation Impact

11.17

Funders

• European Commission
• University of Capetown
• University of Cape Town
• National Institutes of Health
• Congressionally Directed Medical Research Programs
• European and Developing Countries Clinical Trials Partnership